Shares of Biocon Ltd were trading in the green and 2% on 18 September after the companyβs subsidiary, Biocon Biologics, received approval from the US...
Biocon Biologics, a subsidiary of Biocon, reported on Thursday, 10 April, that the US Food and Drug Administration (FDA) had approved its antibody Jobevne. The...
Shares of Biocon Ltd were trading in the green and 2% higher on 24 March after the companyβs subsidiary announced securing approval from the USFDA...
Shares of Biocon, a pharmaceutical company, rose by as much as 2% on Tuesday, 25 February, after Biocon Biologics, a fully integrated global biosimilars company...
Shares of Biocon were trading 4% higher on 13 January after the company’s subsidiary Biocon Biologics’ insulin factory in Malaysia got cleared by the US...
Shares of Biocon Ltd surged 8% on 7 December after the company’s subsidiary, Biocon Biologics, announced approval from Japan’s Pharmaceuticals and Medical Devices Agency. The...